Report Code: A14318 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Controlled release drug delivery is the dosage form that delivers a drug or medication in a predetermined manner. This system of drug delivery provides continuous delivery of drugs or medication in predictable kinetics for the predetermined time in the whole course of gastrointestinal transit. The drug is released until it reaches a specific target in the GI tract. Systems of control release drug delivery employ drug encapsulating devices from which the drug or medication is released at a rate that is controlled for a significantly long period, ranging from days to months.
COVID-19 Scenario Analysis
Top Impacting Factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
Advantages of controlled release drug delivery systems are such as lower dose requirement, improved stability of the drug, minimum side effects, improved drug efficacy and safety, higher bioavailability and enhanced patient compliance. Additionally, rising awareness about the benefits regarding the controlled release drug delivery system as compared to conventional drug delivery systems is likely to prop up the market.
Controlled release drug delivery also enables reduction of the dose which minimizes the risk of overdose in elderly people. Dysphagia for geriatric people or unpleasant taste of pediatric drugs or medication is to act as fuel for adopting the system of controlled release drug delivery. Complicated manufacturing procedures and strict government regulations are factors that are likely to slow the growth of controlled release drug delivery in the forecast timeline.
The targeted drug delivery system is predicted to hold the major share in the market as the huge number of market players have a strong technological portfolio. Key drivers in the market are the rise in the number of ANDA & NDA applications, increase in research and development expenditure and techniques, presence of core market players, growing patient pool with diseases like diabetes requiring prolong treatment, rise in demand for controlled-release medications. The Asia-Pacific market is expected to grow rapidly due to the growing geriatric population, high population growth and rapidly growing pharmaceutical companies. Additionally, the rising focus of key players for expanding the business due to low manufacture costs is likely to grow the market of controlled release drug delivery in the Asia-Pacific.
Key Benefits of the Report
Questions Answered in the Controlled Release Drug Delivery Market Research Report
Controlled Release Drug Delivery Market Report Highlights
Aspects | Details |
---|---|
By Technology Outlook |
|
By Application |
|
By Region |
|
Key Market Players | GE Healthcare, Bayer HealthCare LLC, APOLLO RT Co. Ltd., Nemoto Kyorindo Co., Ltd., Guerbet Group, Ulrich GmbH & Co. KG, VIVID IMAGING, Bracco Group, Sino Medical-Device Technology Co., Ltd, Medtron AG |
Loading Table Of Content...
Start reading.
This Report and over 71,295+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers